Real-time enrollment status for this chronic spontaneous urticaria clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06455202 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Chronic Spontaneous Urticaria |
| Phase | Clinical Trial |
| Target Enrollment | 915 participants |
| Active Locations | 66 sites in the US |
| Sponsor | Celldex Therapeutics |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06455202 is currently active_not_recruiting participants. This clinical trial study for chronic spontaneous urticaria is not currently accepting new participants at 66 locations across the United States. The study is sponsored by Celldex Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06455202 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 66 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06455202 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.